Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for acne relapse and isotretinoin retreatment after initial treatment of acne vulgaris with high-dose isotretinoin: A retrospective cohort study.

Journal of the American Academy of Dermatology·2025
Same author

Biological Glues in Confluent and Reticulated Papillomatosis: Insight Into Tetracycline Efficacy?

Pediatric dermatology·2025
Same author

TYMS-ENOSF1 Dyskeratosis Congenita in a Patient With Ring Chromosome 18: A Case Report.

American journal of medical genetics. Part A·2025
Same author

Agminated Eruptive Melanocytic Nevi and Nail Changes Following Toxic Epidermal Necrolysis in a Pediatric Patient: A Case Report and Systematic Review of the Literature.

Pediatric dermatology·2024
Same author

An expanding violaceous lesion on the plantar surface.

International journal of dermatology·2024
Same author

Treatment Options for Alopecia Areata in Children and Adolescents.

Paediatric drugs·2024
Same journal

Management of Menstrual Disorders in Adolescents of All Abilities.

Pediatric annals·2026
Same journal

The Intersection of Weight Management and Eating Disorders.

Pediatric annals·2026
Same journal

Recognizing and Responding to Complexity in the Medical Care of Adolescents.

Pediatric annals·2026
Same journal

Language Development in Bilingual Children: A Pediatrician's Guide.

Pediatric annals·2026
Same journal

Navigating Identification and Management of Substance Use in Adolescents.

Pediatric annals·2026
Same journal

Risks and Benefits of Social Media on Adolescent Health.

Pediatric annals·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Local Hyperthermia for Warts Treatment
04:25

Local Hyperthermia for Warts Treatment

Published on: November 8, 2024

Immunotherapy for childhood warts.

David A Dasher1, Craig N Burkhart, Dean S Morrell

  • 1Department of Dermatology, UNC Chapel Hill, USA. david_dasher@med.unc.edu

Pediatric Annals
|August 19, 2009
PubMed
Summary
This summary is machine-generated.

Treatment-resistant warts pose a significant challenge. Immunologically-based therapies offer options for difficult-to-treat warts, though further research is needed to confirm their efficacy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 20, 2026

Local Hyperthermia for Warts Treatment
04:25

Local Hyperthermia for Warts Treatment

Published on: November 8, 2024

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Treatment-resistant warts present a common clinical challenge for patients and healthcare providers.
  • Current wart treatments lack uniform effectiveness, necessitating further investigation.

Purpose of the Study:

  • To highlight the need for rigorous randomized controlled trials to establish the efficacy of wart therapies.
  • To present immunologically-based treatments as viable options for patients with refractory warts.

Main Methods:

  • Review of existing literature on wart treatments.
  • Discussion of immunologically-based treatment modalities.

Main Results:

  • No single wart treatment demonstrates universal efficacy.
  • Immunologically-based treatments are not FDA-approved for warts but serve as alternatives for resistant cases.

Conclusions:

  • Individualized treatment approaches are crucial for managing warts.
  • Immunotherapy provides valuable therapeutic options for recalcitrant warts, pending further clinical validation.